Evaluation of the Origin of a Sample of Sporothrix Schenckii that Caused Contamination of a Researcher in Southern Brazil

[1]  M. Cuenca‐Estrella,et al.  Antifungal susceptibility profile in vitro of Sporothrix schenckii in two growth phases and by two methods: microdilution and E‐test , 2010, Mycoses.

[2]  R. Zancopé-Oliveira,et al.  Molecular characterisation of Sporothrix schenckii isolates from humans and cats involved in the sporotrichosis epidemic in Rio de Janeiro, Brazil. , 2009, Memorias do Instituto Oswaldo Cruz.

[3]  C. Kovarik,et al.  Evaluation of cats as the source of endemic sporotrichosis in Peru. , 2008, Medical mycology.

[4]  Clinical,et al.  Reference method for broth dilution antifungal susceptibility testing of filamentous fungi : Approved standard , 2008 .

[5]  J. Guarro,et al.  In Vitro Antifungal Susceptibilities of Five Species of Sporothrix , 2007, Antimicrobial Agents and Chemotherapy.

[6]  V. Mahajan,et al.  Isolation of Sporothrix schenckii from the environmental sources of cutaneous sporotrichosis patients in Himachal Pradesh, India: results of a pilot study , 2007, Mycoses.

[7]  A. Bonifaz,et al.  Sporotrichosis in Childhood: Clinical and Therapeutic Experience in 25 Patients , 2007, Pediatric dermatology.

[8]  T. Ferrari,et al.  Successful treatment of a disseminated Sporothrix schenckii infection and in vitro analysis for antifungal susceptibility testing. , 2007, Diagnostic microbiology and infectious disease.

[9]  J. M. Torres-Rodríguez,et al.  In Vitro Susceptibility of Sporothrix schenckii to Six Antifungal Agents Determined Using Three Different Methods , 2007, Antimicrobial Agents and Chemotherapy.

[10]  T. Cestari,et al.  Viral exanthems in the tropics. , 2007, Clinics in dermatology.

[11]  Daniel D. Miller,et al.  Epidemiological data and molecular characterization (mtDNA) of Sporothrix schenckii in 13 cases from Mexico , 2006, International journal of dermatology.

[12]  J. Guarro,et al.  Molecular Phylogeny of Sporothrix schenckii , 2006, Journal of Clinical Microbiology.

[13]  S. A. Altman,et al.  Macrorestriction Analysis of Clinical and Environmental Isolates of Sporothrix schenckii , 2006, Journal of Clinical Microbiology.

[14]  J. Guarro,et al.  In Vitro Antifungal Susceptibilities of Sporothrix schenckii in Two Growth Phases , 2005, Antimicrobial Agents and Chemotherapy.

[15]  M. L. Scroferneker,et al.  Epidemiology of sporotrichosis: a study of 304 cases in Brazil. , 2005, Journal of the American Academy of Dermatology.

[16]  B. Wanke,et al.  Evaluation of an epidemic of sporotrichosis in cats: 347 cases (1998-2001). , 2004, Journal of the American Veterinary Medical Association.

[17]  H. Ishizaki,et al.  Mitochondrial DNA analysis of Sporothrix schenckii from China, Korea and Spain. , 2004, Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology.

[18]  A. S. Melo,et al.  Evolutionary distances and identification of Candida species in clinical isolates by Randomly Amplified Polymorphic DNA (RAPD) , 2004, Mycopathologia.

[19]  B. Wanke,et al.  Sporothrix schenckii isolated fromdomestic cats with and without sporotrichosis in Rio de Janeiro, Brazil , 2004, Mycopathologia.

[20]  G. Lyon,et al.  Population-based surveillance and a case-control study of risk factors for endemic lymphocutaneous sporotrichosis in Peru. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  F. Queiroz-Telles,et al.  Disseminated cutaneous sporotrichosis in a patient with AIDS: report of a case. , 2002, Revista da Sociedade Brasileira de Medicina Tropical.

[22]  V. Souza,et al.  Phenotyping and Genotyping of Sporothrix schenckii Isolates According to Geographic Origin and Clinical Form of Sporotrichosis , 2002, Journal of Clinical Microbiology.

[23]  O. Oymak,et al.  Case Report. Successfully treated subcutaneous infection with Sporothrix schenckii in Turkey , 2001, Mycoses.

[24]  C. A. Rosa,et al.  Heteroduplex mobility assay of the D1/D2 region of the 26S rDNA for differentiation of Saccharomyces species , 2001, Letters in applied microbiology.

[25]  B. Wanke,et al.  Sporotrichosis: an emergent zoonosis in Rio de Janeiro. , 2001, Memorias do Instituto Oswaldo Cruz.

[26]  B. Bustamante,et al.  Endemic sporotrichosis , 2001, Current opinion in infectious diseases.

[27]  P. Pappas,et al.  Sporotrichosis in Peru: description of an area of hyperendemicity. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  V. Azevedo,et al.  Use of RAPD (random amplified polymorphic DNA) to analyse genetic diversity of dematiaceous fungal pathogens. , 1999, Canadian journal of microbiology.

[29]  A. van Belkum,et al.  Variability of karyotypes and RAPD types in genetically related strains of Cryptococcus neoformans , 1997, Current Genetics.

[30]  M. Beckius,et al.  Spook house sporotrichosis. A point-source outbreak of sporotrichosis associated with hay bale props in a Halloween haunted-house. , 1997, Archives of internal medicine.

[31]  J. Perfect,et al.  Treatment of lymphocutaneous and visceral sporotrichosis with fluconazole. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[32]  J. Martínez-Suárez,et al.  Comparison of two alternative microdilution procedures with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro testing of fluconazole-resistant and -susceptible isolates of Candida albicans , 1995, Journal of clinical microbiology.

[33]  Winn Re.  A contemporary view of sporotrichosis. , 1995 .

[34]  R. Winn.  A contemporary view of sporotrichosis. , 1995, Current topics in medical mycology.

[35]  C. Cooper,et al.  Laboratory-acquired sporotrichosis. , 1992, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[36]  D. Stevens,et al.  A Pan-American 5-year study of fluconazole therapy for deep mycoses in the immunocompetent host. Pan-American Study Group. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37]  J. A. Morello.  Laboratory-Acquired Infections: History, Incidence, Causes and Prevention , 1988 .

[38]  Frank T. Boysia.  Medical mycology. The pathogenic fungi and pathogenic actinomycetes , 1982 .

[39]  J. Rippon.  Medical mycology;: The pathogenic fungi and the pathogenic actinomycetes , 2013 .